The company's purpose is the development, manufacture, and distribution of pharmaceutical and related products, as well as the provision of services for the development, manufacture, and distribution of pharmaceutical and related products. The company may establish branches both domestically and abroad, merge with other enterprises, and acquire, hold, finance, or sell interests in other companies of any kind in Switzerland or abroad. Furthermore, the company may acquire, hold, and dispose of intellectual property rights and licenses of any kind. The company may engage in all commercial, contractual, and financial transactions that are suitable for promoting the company's purpose or are directly or indirectly related thereto. The company may acquire, hold, and dispose of real estate, with the exception of real estate transactions that are prohibited by the Federal Act on the Acquisition of Real Estate by Persons Abroad (BewG). In particular, the company may grant loans and other direct or indirect financings to its direct and indirect subsidiaries and to third parties, including its direct and indirect shareholders and their direct and indirect subsidiaries, within the framework of cash pooling agreements, and provide securities of any kind for their liabilities, including by way of pledges on or fiduciary transfers of assets in the company or guarantees of any kind, whether or not for consideration.